subject: UNII:Z20OC92TDI

object_name: Metastatic Lesion


subject: UNII:Z20OC92TDI

subject_name: ZANIDATAMAB

object_name: Carcinoma breast stage IV

tested_intervention: unsure


subject: UNII:Z20OC92TDI

object_name: Disseminated Malignant Neoplasm


subject: UNII:Z20OC92TDI

object_name: Embolism, Tumor


subject: UNII:Z20OC92TDI

object_name: Neoplasm Metastasis


subject: UNII:Z20OC92TDI

object_name: HER2 low breast cancer


subject: UNII:Z20OC92TDI

object_name: progesterone-receptor positive breast cancer


subject: UNII:Z20OC92TDI

object_name: estrogen-receptor positive breast cancer


subject: UNII:Z20OC92TDI

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:Z20OC92TDI

object_name: hormone receptor-positive breast cancer


subject: UNII:Z20OC92TDI

object_name: HER2-Low Breast Carcinoma


subject: UNII:Z20OC92TDI

object_name: Hormone Receptor-Negative Breast Carcinoma


subject: UNII:Z20OC92TDI

object_name: ERBB2 mutation-related tumors


subject: UNII:Z20OC92TDI

object_name: Estrogen receptor positive tumor


subject: UNII:Z20OC92TDI

object_name: Adult Solid Neoplasm


subject: UNII:Z20OC92TDI

object_name: Solid carcinoma


subject: UNII:Z20OC92TDI

object_name: Childhood Solid Neoplasm


subject: UNII:Z20OC92TDI

object_name: Solid Neoplasm


subject: UMLS:C4331966

subject_name: zanidatamab

object_name: metastatic neoplasm


subject: UMLS:C4331966

object_name: Metastatic Lesion


subject: UMLS:C4331966

object_name: Carcinoma breast stage IV


subject: UMLS:C4331966

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4331966

object_name: Embolism, Tumor


subject: UMLS:C4331966

object_name: Neoplasm Metastasis


subject: UMLS:C4331966

object_name: HER2 low breast cancer


subject: UMLS:C4331966

object_name: progesterone-receptor positive breast cancer


subject: UMLS:C4331966

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C4331966

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4331966

object_name: hormone receptor-positive breast cancer


subject: UMLS:C4331966

object_name: HER2-Low Breast Carcinoma


subject: UMLS:C4331966

object_name: Hormone Receptor-Negative Breast Carcinoma


subject: UMLS:C4331966

object_name: ERBB2 mutation-related tumors


subject: UMLS:C4331966

object_name: Estrogen receptor positive tumor


subject: UMLS:C4331966

object_name: Adult Solid Neoplasm


subject: UMLS:C4331966

object_name: Solid carcinoma


subject: UMLS:C4331966

object_name: Childhood Solid Neoplasm


subject: UMLS:C4331966

object_name: Solid Neoplasm


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: cervical incompetence

tested_intervention: yes


subject: UMLS:C1564085

subject_name: SSKI

object_name: Graves disease


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Port-Wine Stain


subject: CHEBI:474053

subject_name: Cefazolin

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:474053

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:474053

object_name: morbid obesity


subject: CHEBI:474053

object_name: cesarean section; infection


subject: CHEBI:474053

object_name: Pregnant


subject: CHEBI:9570

subject_name: Thiotepa

object_name: Disseminated neuroblastoma


subject: CHEBI:9570

object_name: Stage 4S neuroblastoma


subject: CHEBI:9570

object_name: Localized Resectable Neuroblastoma


subject: CHEBI:9570

object_name: Localized Unresectable Neuroblastoma


subject: CHEBI:75929

object_name: combat disorder


subject: CHEBI:40009

subject_name: Cycloserine


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Harmful pattern of substance use


subject: PUBCHEM.COMPOUND:53477758

object_name: substance abuse


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UNII:J2L7Z273SG

object_name: thyroid tumor


subject: UNII:J2L7Z273SG

object_name: thyroid gland carcinoma


subject: UNII:J2L7Z273SG

object_name: thyroid cancer


subject: UNII:J2L7Z273SG

object_name: colorectal cancer


subject: UNII:J2L7Z273SG

object_name: colorectal carcinoma


subject: UNII:J2L7Z273SG

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:J2L7Z273SG

object_name: non-small cell lung carcinoma


subject: UNII:J2L7Z273SG

object_name: hairy cell leukemia


subject: UNII:J2L7Z273SG

object_name: cholangiocarcinoma


subject: UNII:J2L7Z273SG

object_name: histiocytosis


subject: UNII:J2L7Z273SG

object_name: Histiocytic syndrome


subject: UNII:J2L7Z273SG

object_name: melanoma


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: delayed function of renal transplant


subject: CHEBI:63043

object_name: acute coronary syndrome


subject: CHEBI:63043

object_name: contrast-induced nephropathy


subject: CHEBI:63043

object_name: acute kidney failure


subject: CHEBI:63043

object_name: Acute Kidney Injury, CTCAE


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen

object_name: Endotoxemia


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:100241

subject_name: Ciprofloxacin


subject: CHEBI:167309

subject_name: Methadone

object_name: neonatal opioid withdrawal


subject: CHEBI:8069

subject_name: Phenobarbital


subject: UMLS:C5239449

subject_name: CDA Inhibitor E7727

object_name: Refractory Myelodysplastic Syndrome


subject: UMLS:C5239449

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5239449

object_name: acute myeloid leukemia


subject: UMLS:C5239449

object_name: Myelodysplasia


subject: UMLS:C5239449

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C5239449

object_name: childhood myelodysplastic syndrome


subject: UMLS:C5239449

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C5239449

object_name: Refractory acute myeloid leukemia


subject: UMLS:C5239449

object_name: Recurrent Myelodysplastic Syndrome


subject: UMLS:C5239449

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UMLS:C5239449

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:82960

subject_name: Raltegravir

object_name: Viremia


subject: CHEBI:82960

object_name: Viremia, CTCAE


subject: CHEBI:82960

object_name: Treatment Resistant Disorders


subject: CHEBI:37670

subject_name: protease inhibitor


subject: CHEBI:37670


subject: CHEBI:37670


subject: CHEBI:37670

object_name: HIV-1 infection


subject: UMLS:C0033607

subject_name: Protease Inhibitors


subject: UMLS:C0033607


subject: UMLS:C0033607


subject: UMLS:C0033607


subject: UMLS:C1268897

subject_name: Retroviral protease inhibitor


subject: UMLS:C1268897


subject: UMLS:C1268897


subject: UMLS:C1268897


subject: UMLS:C3536890

subject_name: Protease Inhibitor [EPC]


subject: UMLS:C3536890


subject: UMLS:C3536890


subject: UMLS:C3536890


subject: CHEBI:25187

subject_name: Menthol

object_name: Neck pain


subject: CHEBI:25187

object_name: Neck Pain, CTCAE 5.0


subject: CHEBI:25187

object_name: Neck Pain, CTCAE 3.0


subject: UMLS:C5433203

object_name: opiate dependence


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: Congenital postural scoliosis


subject: UMLS:C3540792

object_name: scoliosis


subject: UMLS:C3540792

object_name: Scoliosis, CTCAE


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: CHEBI:2668

subject_name: Amlodipine

object_name: Cholesterol deposition


subject: UMLS:C0379528

subject_name: gamma-Secretase

object_name: Breast cancer stage II


subject: UMLS:C0379528

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C0379528

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C0379528

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C0379528

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C0379528

object_name: progesterone-receptor positive breast cancer


subject: UMLS:C5777111

object_name: adult lymphoma


subject: UMLS:C5777111

object_name: lymphoma


subject: UMLS:C5777111

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:138684045

object_name: Charcot-Marie-Tooth disease


subject: UMLS:C1134569

subject_name: rF-B7.1 vaccine

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C1134570

subject_name: Recombinant Fowlpox-TRICOM Vaccine


subject: UMLS:C1440584

subject_name: Egg whole

object_name: hypertrophy


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: hepatitis B


subject: PUBCHEM.COMPOUND:2735

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C5417776

subject_name: CYP17/CYP11B2 Inhibitor LAE001

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:131168

subject_name: Afuresertib


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Congenital IGHD


subject: PUBCHEM.COMPOUND:155543961

object_name: Reduced circulating growth hormone concentration


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C3897147

object_name: Renal cell carcinoma recurrent


subject: UMLS:C3897147

object_name: Renal cancer recurrent


subject: CHEBI:27732

subject_name: Caffeine

object_name: Inguinal hernia


subject: CHEBI:52172

subject_name: Nilotinib

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:52172

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:6402

subject_name: Leflunomide

object_name: IgA Nephropathy


subject: CHEBI:6402

object_name: IgA nephropathy, susceptibility to, 1


subject: CHEBI:6402

object_name: Chronic uremia


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604


subject: CHEBI:86474

object_name: neoplasm


subject: CHEBI:18185

subject_name: gamma-Tocopherol

object_name: allergic asthma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: pulmonary venoocclusive disease


subject: CHEBI:45783

subject_name: Imatinib


subject: UMLS:C2348275

subject_name: Dietary Nitrate

object_name: obstructive sleep apnea syndrome


subject: CHEBI:3654

subject_name: Chlorthalidone

object_name: cardio-renal syndrome


subject: CHEBI:9241

subject_name: Spironolactone


subject: CHEBI:25523

subject_name: NADP

object_name: Muscle Atrophy


subject: CHEBI:18009

subject_name: NADP(+)


subject: CHEBI:3639

subject_name: chlorothalonil


subject: PR:000016053

subject_name: tapasin


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Substance Use Disorders


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Overweight and obesity


subject: CHEBI:149504

object_name: Medication interaction potentiation


subject: CHEBI:6541

subject_name: Losartan


subject: UMLS:C3540798

subject_name: Food allergenic extracts


subject: CHEBI:39465

subject_name: timolol

object_name: ulcer disease


subject: CHEBI:39465

object_name: Burn injury


subject: CHEBI:9241

object_name: heart failure; with decompensation


subject: PUBCHEM.COMPOUND:5245480

object_name: liver carcinoma


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Non-small cell lung cancer stage III


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: UNII:953A26OA1Y

subject_name: Dornase alfa

object_name: Recurrent lower respiratory tract infections


subject: UNII:953A26OA1Y

object_name: lung transplant infection


subject: PR:000006592


subject: PR:000006592


subject: UMLS:C0251564

subject_name: Pulmozyme


subject: UMLS:C0251564


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: obstructive lung disease


subject: CHEBI:50275

object_name: lung disorder


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: UNII:48854OTZ5E

subject_name: Lecozotan

object_name: Alzheimer disease type 1


subject: UNII:48854OTZ5E

object_name: Alzheimer disease


subject: PR:000007332

subject_name: Fanconi anemia group C protein

object_name: Childhood Breast Carcinoma


subject: PR:000007332

object_name: breast carcinoma


subject: PR:000007332

object_name: breast cancer


subject: UMLS:C5882209

object_name: kidney failure


subject: UMLS:C1725733

subject_name: ACB (Acebutolol)

object_name: Anterior Cruciate Ligament Injuries


subject: CHEBI:78320

subject_name: Lactic acid

object_name: Type 1 diabetes mellitus with hypoglycemia


subject: UMLS:C1176295

subject_name: Natrium lacticum, Homeopathic preparation


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: arteriovenous malformations of the brain


subject: UNII:856DX0KJ84

subject_name: Neramexane

object_name: Tinnitus


subject: UNII:856DX0KJ84

object_name: Tinnitus, CTCAE 5.0


subject: UNII:856DX0KJ84

object_name: Tinnitus, CTCAE 3.0


subject: UMLS:C1142931

subject_name: neramexane


subject: UMLS:C1142931


subject: UMLS:C1142931


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: Digital ulcer


subject: UMLS:C4707654

subject_name: Fluorethyltyrosine

object_name: brain neoplasm


subject: CHEBI:36939

subject_name: Fluorine F-18


subject: CHEBI:7421

subject_name: NAC

object_name: neurofibromatosis 1


subject: CHEBI:7421

object_name: neurofibromatosis type 1


subject: CHEBI:600103

subject_name: daptomycin

object_name: chronic kidney disease


subject: CHEBI:600103

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:600103

object_name: bacterial infectious disease


subject: CHEBI:16899

subject_name: Mannitol

object_name: Liver transplant disorder


subject: CHEBI:45783

subject_name: Imatinib

object_name: drug resistant Plasmodium falciparum malaria


subject: UMLS:C4305707

subject_name: FavId

object_name: Lymphoma, Low-Grade


subject: UMLS:C1327897

subject_name: Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine


subject: UMLS:C5855621

subject_name: ChAdOx1-PSA/PAP/STEAP1/5T4 Prostate Cancer Vaccine ChAdOx1-PCAQ

object_name: prostate carcinoma


subject: UMLS:C5855621

object_name: prostate cancer


subject: UMLS:C5855620

subject_name: MVA-PSA/PAP/STEAP1/5T4 Prostate Cancer Vaccine MVA-PCAQ


subject: UMLS:C5855620


subject: UNII:WGD229O42W

subject_name: Tenecteplase

object_name: cardiac arrest


subject: UMLS:C0021734

subject_name: Roferon-A

object_name: hairy cell leukemia


subject: CHEBI:144460

subject_name: Gly-Ala-Ala

object_name: glioma


subject: CHEBI:144460

object_name: malignant glioma


subject: CHEBI:144460

object_name: Childhood Astrocytoma


subject: CHEBI:144460

object_name: glioma susceptibility 1


subject: CHEBI:144460

object_name: astrocytic tumor


subject: CHEBI:144460

object_name: astrocytoma


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UMLS:C4033631

subject_name: sacubitril / valsartan

object_name: aortic valve insufficiency


subject: UNII:I9KP509K31

subject_name: Mavodelpar

object_name: glycogen storage disease V


subject: UMLS:C4305710


subject: UMLS:C4524823

object_name: Non-small cell lung cancer stage III


subject: UMLS:C2587184

subject_name: Parenogen

object_name: Post-partum hemorrhage


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: cholecystolithiasis


subject: CHEBI:3215

object_name: gallstones


subject: UMLS:C2095775

subject_name: ampicillins

object_name: endometritis


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:3745

subject_name: clindamycin


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Necrosis of brain caused by ionizing radiation


subject: CHEBI:231679

subject_name: ipilimumab

object_name: stage IIIA melanoma


subject: CHEBI:231679

object_name: stage IIIB melanoma


subject: CHEBI:15365

subject_name: Aspirin

object_name: cerebral amyloid angiopathy


subject: CHEBI:15365

object_name: ACys amyloidosis


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:37941


subject: UMLS:C1328149

object_name: Myelodysplasia


subject: UMLS:C1328149

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C1328149

object_name: childhood myelodysplastic syndrome


subject: UMLS:C1328149

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C1328149

object_name: adult acute myeloid leukemia


subject: UMLS:C1328149

object_name: childhood acute myeloid leukemia


subject: UMLS:C1328149

object_name: acute myeloid leukemia


subject: CHEBI:66910

subject_name: Axitinib


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:15367

subject_name: Tretinoin

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:15367

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:15367

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:15367

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:15367

object_name: B-cell neoplasm


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: Locally Advanced Malignant Solid Neoplasm


subject: CHEBI:75045

object_name: Unresectable Malignant Solid Neoplasm


subject: CHEBI:75045

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:75045

object_name: Locally Advanced Melanoma


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: UNII:ZXM835LQ5E

subject_name: Uprosertib

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: UNII:ZXM835LQ5E

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UNII:ZXM835LQ5E

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:ZXM835LQ5E

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:ZXM835LQ5E


subject: UNII:ZXM835LQ5E


subject: UNII:ZXM835LQ5E


subject: UNII:ZXM835LQ5E


subject: UNII:ZXM835LQ5E

object_name: Unresectable Melanoma


subject: UNII:ZXM835LQ5E

object_name: metastatic melanoma


subject: CHEMBL.COMPOUND:CHEMBL4297861

subject_name: NEIHULIZUMAB

object_name: graft versus host disease


subject: UMLS:C4053675

subject_name: AbGn 168H


subject: PUBCHEM.COMPOUND:135718449


subject: UMLS:C2012940

subject_name: tetrahydrocannabinol (medication)

object_name: fibromyalgia


subject: CHEBI:66964

subject_name: Dronabinol


subject: PUBCHEM.COMPOUND:5281239

subject_name: Fucoxanthin

object_name: abdominal obesity-metabolic syndrome


subject: PUBCHEM.COMPOUND:5281239

object_name: metabolic syndrome X


subject: CHEBI:5186


subject: CHEBI:5186


subject: UMLS:C4085974

object_name: cancer


subject: UMLS:C4085974

object_name: neoplasm


subject: UMLS:C4085974

object_name: melanoma


subject: UNII:VMT7Z23GLM

subject_name: Dimethandrolone Undecanoate

object_name: multiple endocrine neoplasia


subject: CHEBI:231594

subject_name: Norgestrel


subject: UNII:ZB05V621UD

object_name: major depressive disorder


subject: UMLS:C5555855

subject_name: Anti-PD-L1 Monoclonal Antibody/VEGFR1 Fusion Protein HB0025

object_name: renal carcinoma


subject: UMLS:C5555855

object_name: kidney cancer


subject: PUBCHEM.COMPOUND:21014972

subject_name: Telavancin

object_name: bacterial pneumonia


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Hormone sensitive prostate cancer


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: atopic eczema


subject: CHEBI:6702

subject_name: Mazindol

object_name: narcolepsy


subject: CHEBI:6702

object_name: narcolepsy without cataplexy


subject: CHEBI:6702

object_name: narcolepsy-cataplexy syndrome


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: High risk of recurrence, prostate cancer (PRCA)


subject: CHEBI:6427

subject_name: Leuprolide


subject: CHEBI:8382

subject_name: Prednisone


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: PR:000022673

subject_name: antigen 43

object_name: idiopathic aplastic anemia


subject: PR:000013642

subject_name: Ras-related protein Rab-8A


subject: CHEMBL.COMPOUND:CHEMBL2108391

subject_name: HONEY


subject: UMLS:C4287773

subject_name: VLP-encapsulated TLR9 Agonist CMP-001

object_name: metastatic melanoma


subject: UMLS:C4287773

object_name: Advanced Melanoma


subject: UMLS:C4287773

object_name: Unresectable Melanoma


subject: PUBCHEM.COMPOUND:75038

object_name: Diabetes


subject: PUBCHEM.COMPOUND:75038

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:75038

object_name: inherited lipid metabolism disorder


subject: PUBCHEM.COMPOUND:75038

object_name: Dyslipidemia


subject: CHEBI:44245

subject_name: Menaquinone 7


subject: CHEBI:44245


subject: CHEBI:44245


subject: CHEBI:44245


subject: CHEBI:125427

object_name: Adult Solid Neoplasm


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: UMLS:C5446554

object_name: Malignant ascites


subject: UNII:1P05PW62F3

subject_name: CONBERCEPT

object_name: Macular Edema


subject: UNII:1P05PW62F3

object_name: type 2 diabetes mellitus


subject: UMLS:C2352201

subject_name: Conbercept


subject: UMLS:C2352201


subject: CHEBI:74824

subject_name: Thr-Ala


subject: CHEBI:74824


subject: PUBCHEM.COMPOUND:4532223

subject_name: Tantalum


subject: PUBCHEM.COMPOUND:4532223


subject: PR:000006886

subject_name: ectodysplasin-A


subject: PR:000006886


subject: PR:000016550


subject: PR:000016550


subject: CHEBI:60269

subject_name: trisodium phosphonoformate hexahydrate

object_name: herpes zoster


subject: CHEBI:127780

subject_name: Foscarnet


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Raynaud disease


subject: CHEBI:177512

subject_name: Sagopilone

object_name: small cell lung carcinoma


subject: UMLS:C2930786


subject: UMLS:C4039583

subject_name: Chimeric antigen receptor

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C4039583

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UMLS:C4039583

object_name: B-cell childhood acute lymphoblastic leukemia


subject: UMLS:C4039583

object_name: B-cell adult acute lymphocytic leukemia


subject: UMLS:C4039583

object_name: B-cell acute lymphoblastic leukemia


subject: UMLS:C4039583

object_name: mantle cell lymphoma


subject: UMLS:C4039583

object_name: follicular lymphoma


subject: UMLS:C4039583

object_name: lymphoplasmacytic lymphoma


subject: UMLS:C4039583

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C4039583

object_name: marginal zone lymphoma


subject: UMLS:C4039583

object_name: MALT lymphoma


subject: UMLS:C4039583

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: CHEBI:71954

subject_name: Buparlisib


subject: CHEBI:71954

object_name: Mantle cell lymphoma refractory


subject: CHEBI:71954

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: HMDB:HMDB0015666

subject_name: Lornoxicam

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:152165

object_name: Biliary Colic


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:44915

subject_name: Propofol


subject: PUBCHEM.COMPOUND:135565610

subject_name: hetrombopag

object_name: Thalassemia in children


subject: UNII:9WGT51BDDL

subject_name: Hetrombopag


subject: CHEBI:229778

object_name: Frontal balding


subject: UniProtKB:P0A6Z1

subject_name: HSCA_ECOLI Chaperone protein HscA (sprot)


subject: PR:000007702


subject: PR:000022925

subject_name: chaperone protein HscA


subject: CHEMBL.COMPOUND:CHEMBL5095385

subject_name: NANRILKEFUSP ALFA

object_name: castration-resistant prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C5417804

subject_name: RLI 15


subject: UMLS:C5417804


subject: CHEBI:167655

object_name: unspecified childhood solid tumor, protocol specific


subject: UNII:V5PC588N7G

subject_name: Mag 2 (TN)

object_name: Family history of diabetes mellitus


subject: CHEBI:16010


subject: CHEBI:31348

subject_name: Capecitabine

object_name: inflammatory breast carcinoma


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: CHEBI:6402

subject_name: Leflunomide

object_name: autoimmune disease, multisystem, infantile-onset, 2


subject: CHEBI:233414

object_name: glioma susceptibility 1


subject: CHEBI:233414

object_name: adult oligodendroglioma


subject: CHEBI:233414

object_name: oligodendroglioma


subject: CHEBI:233414

object_name: childhood oligodendroglioma


subject: CHEBI:233414

object_name: glioblastoma


subject: CHEBI:233414

object_name: Childhood Glioblastoma


subject: CHEBI:233414

object_name: adult glioblastoma


subject: CHEBI:233414

object_name: Childhood Astrocytoma


subject: CHEBI:233414

object_name: astrocytic tumor


subject: CHEBI:233414

object_name: astrocytoma


subject: MESH:C552724

subject_name: OKN 007


subject: MESH:C552724


subject: MESH:C552724


subject: MESH:C552724


subject: MESH:C552724


subject: MESH:C552724


subject: MESH:C552724


subject: UMLS:C0062527

subject_name: Engerix-B

object_name: hepatitis B vaccine (history)


subject: UMLS:C3541932

subject_name: Moringa oleifera extract

object_name: Dental Plaque


subject: UMLS:C3541932

object_name: cytotoxicity


subject: UMLS:C1670100

subject_name: tigapotide

object_name: prostate carcinoma


subject: UMLS:C1670100

object_name: prostate cancer


subject: UNII:7662KG2R6K

subject_name: Lubiprostone

object_name: Adverse drug response


subject: PUBCHEM.COMPOUND:5316

subject_name: Sulbactam

object_name: preterm premature rupture of the membranes


subject: UMLS:C2095775

subject_name: ampicillins


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:29007

subject_name: Ceftriaxone


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:16919

subject_name: Creatine

object_name: Paresis


subject: CHEBI:16919

object_name: Muscle weakness


subject: UMLS:C5446373

subject_name: CDK2 Inhibitor PF-07104091

object_name: Well adult


subject: CHEBI:60802

subject_name: ropivacaine

object_name: migraine


subject: CHEBI:60802

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:64312

subject_name: Memantine

object_name: Frontal lobe dementia


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Arrhythmia


subject: CHEBI:33569

object_name: Nausea, CTCAE_5


subject: CHEBI:33569

object_name: Nausea


subject: CHEBI:33569

object_name: Nausea, CTCAE_3


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: bipolar II disorder


subject: CHEBI:10119

object_name: major depressive episode


subject: CHEBI:151315

subject_name: Heparin

object_name: type 2 diabetes mellitus


subject: KEGG.COMPOUND:C00374


subject: CHEBI:27732

subject_name: Caffeine

object_name: Finding relating to sexuality and sexual activity


subject: UMLS:C5392196

subject_name: Hexavalent Vaccines

object_name: poliomyelitis


subject: UMLS:C5442122

subject_name: VITAMIN B

object_name: pain agnosia


subject: UMLS:C5442122

object_name: Pain insensitivity


subject: UMLS:C5442122

object_name: Post-Operative Pain


subject: UMLS:C1704763

subject_name: B Vitamin Family


subject: UMLS:C1704763


subject: UMLS:C1704763


subject: CHEBI:75769

subject_name: B vitamin


subject: CHEBI:75769


subject: CHEBI:75769


subject: CHEMBL.COMPOUND:CHEMBL2108015

subject_name: VITAMIN B COMPLEX


subject: CHEMBL.COMPOUND:CHEMBL2108015


subject: CHEMBL.COMPOUND:CHEMBL2108015


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: bipolar disorder


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: acute lung injury


subject: UNII:O9YF5SN7KL

subject_name: ROZIBAFUSP ALFA

object_name: rheumatoid arthritis


subject: UMLS:C5420958

subject_name: rozibafusp alfa


subject: UMLS:C0003448

subject_name: Antitubercular Agents

object_name: tuberculosis


subject: UMLS:C3195090

subject_name: Evicel

object_name: osteoarthritis, knee


subject: UMLS:C1530229

subject_name: Arcoxia

object_name: no feeling or sensation of skin


subject: UMLS:C1530229

object_name: Sensory Loss


subject: UMLS:C1530229

object_name: Regional anesthesia morbidity


subject: UMLS:C1530229

object_name: Anesthesia morbidity


subject: UMLS:C1530229

object_name: Breast neoplasm female


subject: CHEBI:6339

subject_name: Etoricoxib


subject: CHEBI:6339


subject: CHEBI:6339


subject: CHEBI:6339


subject: CHEBI:6339


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: UMLS:C3248676

subject_name: ONDANSETRON, ORAL, 4 MG (FOR CIRCUMSTANCES FALLING UNDER THE MEDICARE STATUTE, USE HCPCS Q CODE)


subject: UMLS:C3248676


subject: UMLS:C3248676


subject: UMLS:C3248676


subject: UMLS:C3248676


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UNII:JXH6X663L0

subject_name: Veliflapon

object_name: acute coronary syndrome


subject: UMLS:C0656891

subject_name: Bay X 1005


subject: CHEBI:6121

subject_name: Ketamine

object_name: cancer


subject: CHEBI:6121

object_name: neoplasm


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: CHEBI:135918

object_name: T-cell lymphoma refractory


subject: CHEBI:16302

object_name: diarrhea


subject: CHEBI:16302

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:16302

object_name: Diarrhea, CTCAE


subject: CHEBI:16302

object_name: respiratory tract infectious disorder


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: CHEBI:12777

subject_name: Vitamin A


subject: CHEBI:12777


subject: CHEBI:12777


subject: CHEBI:12777


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: UNII:2158753C7E

subject_name: Relacorilant

object_name: Solid Neoplasm


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Acute schizophrenic episode


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate

object_name: Alzheimer disease


subject: CHEBI:16919

subject_name: Creatine


subject: UMLS:C5706510

subject_name: Oncolytic RNA Virus IVX037

object_name: ovarian cancer


subject: UMLS:C5706510

object_name: ovarian neoplasm


subject: UMLS:C5706510

object_name: ovarian carcinoma


subject: UMLS:C5706510

object_name: colorectal cancer


subject: UMLS:C5706510

object_name: colorectal carcinoma


subject: UMLS:C5706510

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5706510

object_name: Stomach cancer


subject: UMLS:C5706510

object_name: gastric cancer


subject: GTOPDB:12990

subject_name: sintilimab


subject: GTOPDB:12990


subject: GTOPDB:12990


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: CHEBI:78825

subject_name: Avutometinib

object_name: Advanced cancer


subject: CHEBI:78825

object_name: cancer


subject: CHEBI:78825

object_name: lung cancer


subject: UMLS:C2703210


subject: UMLS:C2703210


subject: CHEBI:145421

subject_name: rigosertib sodium

object_name: liver neoplasm


subject: CHEBI:145421

object_name: liver carcinoma


subject: CHEBI:145421

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C2347619


subject: UMLS:C2347619


subject: UMLS:C2347619


subject: CHEBI:77590

subject_name: Armodafinil

object_name: Childhood Breast Carcinoma


subject: CHEBI:77590

object_name: breast carcinoma


subject: CHEBI:77590

object_name: breast cancer


subject: CHEBI:18276

subject_name: Hydrogen


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON

object_name: lymphomatoid granulomatosis


subject: CHEMBL.COMPOUND:CHEMBL2108494

object_name: lymphoproliferative syndrome


subject: CHEMBL.COMPOUND:CHEMBL2108494

object_name: non-Hodgkin lymphoma


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C3652465


subject: UMLS:C3652465


subject: UMLS:C0021747

subject_name: Interferons


subject: UMLS:C0021747


subject: UMLS:C0733470

subject_name: human leukocyte interferon


subject: UMLS:C0733470


subject: UMLS:C0295415

subject_name: rituximab


subject: PUBCHEM.COMPOUND:56841998

subject_name: Epoch


subject: PUBCHEM.COMPOUND:56841998


subject: PUBCHEM.COMPOUND:56841998


subject: CHEBI:10127

subject_name: Zonisamide

object_name: Partial Seizure


subject: UNII:7CDW97HUEX

subject_name: Linzagolix

object_name: Hepatic impairment


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: adrenal cortex carcinoma


subject: UNII:DLE8519RWM

object_name: adenoid cystic carcinoma


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib


subject: UMLS:C1879771

subject_name: BIBF 1120


subject: CHEBI:85164


subject: CHEBI:31399

subject_name: Cilnidipine

object_name: autosomal dominant polycystic kidney disease


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: EXCESS LMW-DNA


subject: CHEBI:85078

object_name: st. Louis encephalitis


subject: CHEBI:139072

object_name: post-treatment Lyme disease syndrome


subject: CHEBI:139072

object_name: chronic lyme disease


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: childhood acute lymphoblastic leukemia


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: CHEBI:59173

subject_name: Bivalirudin


subject: CHEBI:4672

subject_name: Docetaxel

object_name: human papilloma virus infection


subject: CHEBI:4672

object_name: Oropharyngeal squamous cell carcinoma stage I


subject: CHEBI:4672

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: lymphocytic gastritis


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:93775

subject_name: Amethopterin

object_name: extranodal nasal NK/T cell lymphoma


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: UNII:7D96IR0PPM


subject: CHEBI:2948

subject_name: Azathioprine

object_name: mucopolysaccharidosis type 1


subject: CHEBI:55379

subject_name: camphorsulfonic acid


subject: PR:000007170

subject_name: DNA excision repair protein ERCC-8


subject: UMLS:C1446748

subject_name: Pleurotus ostreatus antigen

object_name: hyperlipidemia


subject: UMLS:C1446748

object_name: hyperlipoproteinemia


subject: UMLS:C1446748

object_name: Hyperlipidemia, CTCAE


subject: UMLS:C1446748

object_name: Serum lipids high (finding)


subject: UMLS:C1446748

object_name: HIV infection


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Stage II Esophageal Squamous Cell Carcinoma AJCC v7


subject: GTOPDB:9592

object_name: Esophageal squamous cell carcinoma stage II


subject: GTOPDB:9592

object_name: Stage III Esophageal Squamous Cell Carcinoma AJCC v7


subject: GTOPDB:9592

object_name: Esophageal squamous cell carcinoma stage III


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: MESH:C000604051

subject_name: danshen dripping pill

object_name: coronary artery disorder


subject: MESH:C000604051

object_name: essential hypertension


subject: UMLS:C1527127

object_name: melanoma


subject: CHEBI:139072

object_name: conversion disorder


subject: CHEBI:139072

object_name: Dissociative neurological symptom disorder (disorder)


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: MESH:C555877

subject_name: Remaxol

object_name: cholelithiasis


subject: CHEBI:27953

subject_name: Physostigmine

object_name: schizophrenia


subject: UNII:TWQ8K8A81Y

subject_name: Larotaxel

object_name: pancreatic neoplasm


subject: UMLS:C2603884


subject: UMLS:C5854467

subject_name: Anti-CD19/CD3 T-cell Engaging Bispecific Antibody CLN-978

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UMLS:C5854467

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5854467

object_name: non-Hodgkin lymphoma


subject: UMLS:C5854467

object_name: Lymphoma, Large-Cell, Follicular


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Cicatrization


subject: UNII:UC95NQ339C

object_name: Cicatrix, Hypertrophic


subject: CHEBI:231352

subject_name: Resminostat

object_name: liver carcinoma


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Femoroacetabular impingement


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: UNII:1A7Y9MP123

object_name: non-small cell lung carcinoma


subject: UNII:1A7Y9MP123

object_name: Neck Carcinoma


subject: UNII:1A7Y9MP123

object_name: head and neck neoplasm


subject: UNII:1A7Y9MP123

object_name: head and neck cancer


subject: UNII:1A7Y9MP123

object_name: Stomach cancer


subject: UNII:1A7Y9MP123

object_name: gastric cancer


subject: UNII:1A7Y9MP123

object_name: Childhood Breast Carcinoma


subject: UNII:1A7Y9MP123

object_name: breast carcinoma


subject: UNII:1A7Y9MP123

object_name: breast cancer


subject: UNII:1A7Y9MP123

object_name: liver cancer


subject: UNII:1A7Y9MP123

object_name: liver neoplasm


subject: UNII:1A7Y9MP123

object_name: Adult Liver Carcinoma


subject: UNII:1A7Y9MP123


subject: UMLS:C2703140


subject: UMLS:C2703140


subject: UMLS:C2703140


subject: UMLS:C2703140


subject: UMLS:C2703140


subject: UMLS:C2703140


subject: UMLS:C2703140


subject: UMLS:C2703140


subject: UMLS:C2703140


subject: UMLS:C2703140


subject: UMLS:C2703140


subject: UMLS:C2703140


subject: UMLS:C2703140


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Inoperable Disease


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: PUBCHEM.COMPOUND:3685

object_name: lung cancer


subject: PUBCHEM.COMPOUND:3685

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:3685

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:119915

subject_name: Fentanyl

object_name: induced; birth


subject: CHEBI:6456

subject_name: Lidocaine


subject: UMLS:C5827087

object_name: X-linked retinitis pigmentosa


subject: CHEBI:6532

subject_name: Loperamide

object_name: colitis


subject: CHEBI:6532

object_name: Colitis, CTCAE


subject: CHEBI:6532


subject: CHEBI:6532


subject: CHEBI:6532


subject: CHEBI:6532

object_name: Genitourinary Cancer


subject: CHEBI:6532

object_name: uterine cancer


subject: CHEBI:6532

object_name: tumor of uterus


subject: CHEBI:6532

object_name: cervical cancer


subject: CHEBI:6532

object_name: cervical carcinoma


subject: CHEBI:6532

object_name: melanoma


subject: CHEBI:6121

subject_name: Ketamine

object_name: acute kidney failure


subject: CHEBI:6121

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C1564283

subject_name: Propofol Fresenius

object_name: nervous system disorder


subject: CHEBI:44915

subject_name: Propofol


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam


subject: UNII:3S9RX35S5X

subject_name: Fimepinostat

object_name: Recurrent Medulloblastoma


subject: UNII:3S9RX35S5X

object_name: Recurrent Childhood Medulloblastoma


subject: UNII:3S9RX35S5X

object_name: diffuse midline glioma, H3 K27M-mutant


subject: UNII:3S9RX35S5X

object_name: diffuse intrinsic pontine glioma


subject: UNII:3S9RX35S5X

object_name: Recurrent Childhood Glioblastoma


subject: UNII:3S9RX35S5X

object_name: Recurrent Glioblastoma


subject: UNII:3S9RX35S5X

object_name: Recurrent Malignant Glioma


subject: UNII:3S9RX35S5X

object_name: Recurrent Anaplastic Astrocytoma


subject: UNII:3S9RX35S5X

object_name: Recurrent Childhood Anaplastic Astrocytoma


subject: CHEBI:49662

subject_name: Indomethacin

object_name: Light for dates


subject: CHEBI:49662

object_name: Premature infant


subject: CHEBI:49662

object_name: Premature birth


subject: UMLS:C5237724

subject_name: Zeripatamig

object_name: primary mediastinal large B-cell lymphoma


subject: UMLS:C5237724

object_name: Indolent Non-Hodgkin Lymphoma


subject: UMLS:C5237724

object_name: Indolent lymphoma


subject: UMLS:C5237724

object_name: Aggressive Non-Hodgkin Lymphoma


subject: UMLS:C5237724

object_name: follicular lymphoma


subject: UMLS:C5237724

object_name: marginal zone lymphoma


subject: UMLS:C5237724

object_name: MALT lymphoma


subject: UMLS:C5237724

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5237724

object_name: chronic leukemia


subject: UMLS:C5237724

object_name: mantle cell lymphoma


subject: UMLS:C5237724

object_name: mast cell leukemia


subject: UMLS:C5237724

object_name: Multiple cutaneous leiomyomas


subject: UMLS:C5237724

object_name: Richter syndrome


subject: UMLS:C5237724

object_name: diffuse large B-cell lymphoma


subject: UNII:U59UGK3IPC

subject_name: Ublituximab


subject: UNII:U59UGK3IPC


subject: UNII:U59UGK3IPC


subject: UNII:U59UGK3IPC


subject: UNII:U59UGK3IPC


subject: UNII:U59UGK3IPC


subject: UNII:U59UGK3IPC


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C5417898

subject_name: Hsp90-targeted Photosensitizer HS-201

object_name: Childhood Solid Neoplasm


subject: UMLS:C5417898

object_name: Adult Solid Neoplasm


subject: UMLS:C5417898

object_name: Solid Neoplasm


subject: CHEBI:76611

subject_name: flutemetamol

object_name: Alzheimer disease type 1


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Infection


subject: CHEBI:28939

object_name: infectious disease


subject: CHEBI:28939

object_name: Adverse Event Associated with Infection


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421


subject: CHEBI:7421


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: retinal degeneration


subject: CHEBI:168243

object_name: retinal disease


subject: CHEBI:168243

object_name: Eye Diseases, Hereditary


subject: CHEBI:168243

object_name: eye disorder


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: UMLS:C5418043

subject_name: ADC SHR-A1811

object_name: Breast cancer stage II


subject: UMLS:C5418043

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C5418043

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C5418043

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C5418043

object_name: Stage III Breast Cancer AJCC v7


subject: UMLS:C5418043

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UMLS:C5418043

object_name: Breast cancer stage III


subject: UMLS:C5418043

object_name: Stage III Breast Cancer AJCC v6


subject: UMLS:C5418043

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:9824461

object_name: mouth disorder


subject: PUBCHEM.COMPOUND:9824461

object_name: disorder of pharynx


subject: PUBCHEM.COMPOUND:9824461

object_name: laryngeal disorder


subject: PUBCHEM.COMPOUND:9824461

object_name: nasal disorder


subject: CHEBI:167309

subject_name: Methadone

object_name: Pain, Intractable


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Pancreatic Cyst


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage I Uterine Corpus Cancer


subject: CHEBI:31355

object_name: neurotoxicity


subject: CHEBI:31355

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:31355

object_name: obesity


subject: CHEBI:31355

object_name: Obesity, CTCAE


subject: CHEBI:31355

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:31355

object_name: Fatigue


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:60775

subject_name: Verteporfin

object_name: Prostate cancer recurrent


subject: CHEMBL.COMPOUND:CHEMBL5314346

subject_name: VERTEPORFIN


subject: CHEBI:6504

object_name: multiple system atrophy


subject: CHEBI:17437

subject_name: Dimethylsulfide

object_name: osteoarthritis, knee


subject: CHEBI:137338

subject_name: Val-Ala-Gly

object_name: vulvovaginal candidiasis


subject: CHEBI:46081

subject_name: Fluconazole


subject: UMLS:C5446652

subject_name: Anti-survivin T-cell Receptor/Anti-CD3 Bispecific Therapeutic ABBV-184

object_name: adult acute myeloid leukemia


subject: UMLS:C5446652

object_name: childhood acute myeloid leukemia


subject: UMLS:C5446652

object_name: acute myeloid leukemia


subject: UMLS:C5446652

object_name: cancer


subject: UMLS:C5446652

object_name: neoplasm


subject: UMLS:C5446652

object_name: non-small cell lung carcinoma


subject: UMLS:C5784794

subject_name: Anti-LILRB2 Monoclonal Antibody BMS-986406

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:54675783

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:54675783

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:74705

subject_name: Met-Leu

object_name: coronary atherosclerosis


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:6931

subject_name: Midazolam

object_name: plasma cell myeloma


subject: UMLS:C3688175

subject_name: Olive Oil Solutions, Ozonized

object_name: transient myeloproliferative syndrome


subject: UMLS:C3688175

object_name: tibial muscular dystrophy


subject: UMLS:C3688175

object_name: temporomandibular joint dysfunction syndrome


subject: UMLS:C3688175

object_name: temporomandibular joint disorder


subject: UMLS:C5203352

subject_name: Carboplatin Liquid Injection

object_name: cervical cancer


subject: UMLS:C5203352

object_name: cervical carcinoma


subject: UMLS:C0499106

subject_name: Injection, carboplatin, 50 mg


subject: UMLS:C0499106


subject: UMLS:C5400115

subject_name: Cisplatin Liquid Injection


subject: UMLS:C5400115


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: elevated lipoprotein (a)


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: congenital amegakaryocytic thrombocytopenia 1


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V

object_name: Diamond-Blackfan anemia


subject: UNII:3A189DH42V

object_name: Aase syndrome


subject: UNII:3A189DH42V

object_name: severe congenital neutropenia


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:95341

subject_name: Baricitinib

object_name: long COVID-19


subject: KEGG.COMPOUND:C00374

subject_name: Heparin

object_name: pulmonary embolism


subject: CHEBI:2965

object_name: proteinuria


subject: CHEBI:2965

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:2965

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:2965

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:2965

object_name: chronic kidney disease


subject: CHEBI:2965

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C0379142


subject: UMLS:C0379142


subject: UMLS:C0379142


subject: UMLS:C0379142


subject: UMLS:C0379142


subject: UMLS:C0379142


subject: CHEBI:145499

subject_name: Donepezil

object_name: Mixed Dementias


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin

object_name: Critical Illness


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Family history of ischemic heart disease


subject: CHEBI:44915

subject_name: Propofol

object_name: myocardial ischemia


subject: CHEBI:44915


subject: CHEBI:9316

subject_name: Sufentanil


subject: UMLS:C5564654

object_name: Atopic rhinitis


subject: UMLS:C5564654

object_name: Allergic Rhinitis, CTCAE


subject: UMLS:C5959098

subject_name: PD-1 Targeted IL-2 Mutein Fusion Protein KY-0118

object_name: Neoplasms by Histologic Type


subject: UMLS:C5959098

object_name: neoplasm


subject: CHEBI:74705

subject_name: Met-Leu

object_name: beriberi


subject: CHEBI:74705

object_name: Thiamine deficiency


subject: CHEBI:74705

object_name: Decreased circulating vitamin B1 concentration


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: UMLS:C4287773

subject_name: VLP-encapsulated TLR9 Agonist CMP-001

object_name: head and neck squamous cell carcinoma


subject: CHEBI:2663

subject_name: Amiodarone

object_name: autosomal dominant polycystic kidney disease


subject: CHEBI:31596

subject_name: Febuxostat


subject: UMLS:C4705566

object_name: osteoarthritis, knee


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: BH4-deficient hyperphenylalaninemia A


subject: GTOPDB:9110

object_name: Childhood Breast Carcinoma


subject: GTOPDB:9110

object_name: breast carcinoma


subject: GTOPDB:9110

object_name: breast cancer


subject: UMLS:C2703205


subject: UMLS:C2703205


subject: UMLS:C2703205


subject: CHEBI:90881

subject_name: Camptosar

object_name: renal pelvis/ureter urothelial carcinoma


subject: CHEBI:90881

object_name: carcinoma of urethra


subject: CHEBI:90881

object_name: urethra cancer


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: healthy, no evidence of disease


subject: CHEBI:61397

subject_name: Neratinib

object_name: bladder tumor


subject: CHEBI:61397

object_name: urinary bladder carcinoma


subject: CHEBI:61397

object_name: urinary bladder cancer


subject: CHEBI:61397

object_name: childhood bladder carcinoma


subject: UMLS:C1517800

subject_name: Imo (pharmacologic substance)

object_name: Diet, Healthy


subject: UMLS:C1165603

subject_name: Dextrose solution


subject: CHEBI:17234

subject_name: D-glucose


subject: HMDB:HMDB0000668

subject_name: Hematoporphyrin IX


subject: CHEBI:147379

subject_name: His-Pro


subject: CHEBI:24526

subject_name: heptyl group


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: CHEBI:91951

object_name: prostate neoplasm


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: UNII:210323T9CP

object_name: neuralgia


subject: UNII:210323T9CP

object_name: Neuropathic pain


subject: PUBCHEM.COMPOUND:24752296


subject: PUBCHEM.COMPOUND:24752296


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Fractured forearm bone


subject: CHEBI:41879

object_name: Hand Fracture


subject: CHEBI:41879

object_name: wrist fracture


subject: CHEBI:41879

object_name: Fractured carpal bone


subject: CHEBI:41879

object_name: Wrist Fracture, CTCAE


subject: CHEBI:41879

object_name: Hand Injuries


subject: CHEBI:41879

object_name: Wrist Injuries


subject: MESH:C414006

subject_name: 23-valent pneumococcal capsular polysaccharide vaccine

object_name: pneumonia


subject: MESH:C414006

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:32599

object_name: chronic pain syndrome


subject: UMLS:C3896878

subject_name: Anti-ETBR/MMAE Antibody-Drug Conjugate DEDN6526A

object_name: melanoma


subject: UMLS:C1699394

subject_name: Hylenex

object_name: Cardiac Output


subject: UMLS:C1699394

object_name: cardiac catheterization cardiac output in liters per minute


subject: UMLS:C3273940

subject_name: Copper Cu 64 TP3805

object_name: urothelial carcinoma


subject: UMLS:C3273940

object_name: transitional cell carcinoma


subject: UMLS:C3273940

object_name: bladder transitional cell carcinoma


subject: UMLS:C5907921

subject_name: Anti-CD19/Anti-CD3/Anti-CD28 Trispecific Antibody CC312

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5907921

object_name: non-Hodgkin lymphoma


subject: UMLS:C5907921

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C5907921

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C5907921

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5907921

object_name: acute lymphoblastic leukemia


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: light chain deposition disease


subject: CHEBI:134726

subject_name: Istradefylline

object_name: Cognitive impairment


subject: CHEBI:48390

subject_name: Cinacalcet

object_name: vitamin D-dependent rickets, type 2


subject: CHEBI:48390

object_name: X-linked hypophosphatemic rickets


subject: PUBCHEM.COMPOUND:118279413

subject_name: MINZASOLMIN

object_name: Parkinson disease


subject: UNII:3N0435TG2D


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Anemia in chronic kidney disease


subject: UNII:S3F315JJXI

object_name: Acne inversa


subject: UNII:3X8387Q25N


subject: UMLS:C5565842


subject: CHEBI:135207

subject_name: Clofedanol

object_name: hypertension


subject: CHEBI:135207

object_name: Hypertension, CTCAE


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: bipolar disorder


subject: CHEBI:16724

object_name: endogenous depression


subject: CHEBI:16724

object_name: major depressive disorder


subject: CHEBI:30830

subject_name: sodium oxybate


subject: CHEBI:30830


subject: MESH:D010919

subject_name: Placebos


subject: MESH:D010919


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Clear-cell metastatic renal cell carcinoma


subject: UNII:M89N0Q7EQR

object_name: Advanced Clear Cell Renal Cell Carcinoma


subject: PR:000001379


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Stage III renal cell cancer


subject: UNII:DPT0O3T46P

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UNII:DPT0O3T46P


subject: CHEBI:74947

subject_name: Thalidomide

object_name: discoid lupus erythematosus


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: aggressive NK-cell leukemia


subject: UMLS:C1446777

subject_name: Rabbit antigen


subject: UMLS:C2093603

subject_name: Rabbit


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab


subject: UNII:4FR53SIF3A

object_name: Hodgkin Disease


subject: UNII:4FR53SIF3A

object_name: Adult Hodgkin Lymphoma


subject: UNII:4FR53SIF3A

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: GTOPDB:4934

subject_name: G-CSF


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:15365

subject_name: Aspirin

object_name: COPD, severe early onset


subject: CHEBI:15365

object_name: chronic obstructive pulmonary disease


subject: CHEBI:4325

subject_name: Dapsone

object_name: stroke disorder


subject: CHEBI:4325

object_name: cerebrovascular disorder


subject: CHEBI:4325

object_name: Stroke (heart beat)


subject: CHEBI:4325

object_name: Stroke, CTCAE


subject: CHEBI:4325

object_name: Acute Stroke


subject: DRUGBANK:DB18143

subject_name: MTL-CEBPA

object_name: Adult Solid Neoplasm


subject: MESH:D000077331

subject_name: Ringer's Solution

object_name: Joint hypermobility


subject: MESH:D000077331

object_name: hypermobility syndrome


subject: CHEBI:59729

subject_name: fenfluramine hydrochloride

object_name: craniodiaphyseal dysplasia, autosomal dominant


subject: CHEBI:59729

object_name: craniodiaphyseal dysplasia


subject: CHEBI:5000

subject_name: Fenfluramine


subject: CHEBI:5000


subject: UMLS:C2830125

object_name: peritoneum cancer


subject: UMLS:C2830125

object_name: ovarian carcinoma


subject: UMLS:C2830125

object_name: malignant epithelial tumor of ovary


subject: UMLS:C2830125

object_name: fallopian tube carcinoma


subject: UMLS:C2830125

object_name: fallopian tube cancer


subject: CHEBI:145371

subject_name: Binimetinib


subject: CHEBI:145371


subject: CHEBI:145371


subject: PUBCHEM.COMPOUND:135742497

subject_name: MEK inhibitor


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: UMLS:C2347168

subject_name: Mitogen-Activated Protein Kinase Kinase Inhibitor


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: CHEBI:64911

subject_name: antimitotic


subject: CHEBI:64911


subject: CHEBI:64911


subject: CHEBI:64911


subject: CHEBI:64911


subject: UMLS:C0003379

subject_name: Antimitotic Agents


subject: UMLS:C0003379


subject: UMLS:C0003379


subject: UMLS:C0003379


subject: UMLS:C0003379


subject: UNII:WSU5343074

object_name: hepatitis C


subject: UNII:WSU5343074

object_name: chronic hepatitis C virus infection


subject: UMLS:C2348949

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: basal cell carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: skin basal cell carcinoma


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:135659064

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:135659064


subject: PUBCHEM.COMPOUND:135659064


subject: PUBCHEM.COMPOUND:135659064


subject: CHEBI:66903

subject_name: Vismodegib

object_name: metastatic colorectal cancer


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: macular degeneration


subject: UNII:4F4X42SYQ6

object_name: age-related macular degeneration


subject: UNII:4F4X42SYQ6

object_name: retinitis pigmentosa 30


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: acute cholecystitis


subject: PUBCHEM.COMPOUND:6096882

object_name: acute cholangitis


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: CHEBI:93775

subject_name: Amethopterin

object_name: B-cell lymphoma refractory


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:90930

subject_name: Aripiprazole lauroxil

object_name: schizophreniform disorder


subject: CHEBI:90930

object_name: Schizoaffective disorder, depressive type


subject: CHEBI:73614

subject_name: Met-Thr

object_name: stroke disorder


subject: CHEBI:73614

object_name: cerebrovascular disorder


subject: CHEBI:73614

object_name: Stroke (heart beat)


subject: CHEBI:73614

object_name: Stroke, CTCAE


subject: CHEBI:73614

object_name: Hemiparesis


subject: CHEBI:33361

subject_name: meitnerium atom


subject: CHEBI:33361


subject: CHEBI:33361


subject: CHEBI:33361


subject: CHEBI:33361


subject: PR:000010231

subject_name: malonyl-CoA-acyl carrier protein transacylase, mitochondrial


subject: PR:000010231


subject: PR:000010231


subject: PR:000010231


subject: PR:000010231


subject: PUBCHEM.COMPOUND:2091

object_name: adolescent idiopathic scoliosis


subject: CHEBI:31186

subject_name: Alfacalcidol


subject: UMLS:C0815017

subject_name: Angiotensin Receptor Antagonists

object_name: Increased reactive oxygen species production


subject: UMLS:C3536837

subject_name: Angiotensin Converting Enzyme Inhibitor [EPC]


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Paraproteinemia


subject: PUBCHEM.COMPOUND:46783403

object_name: monoclonal gammopathy of uncertain significance


subject: PUBCHEM.COMPOUND:46783403

object_name: IgA Monoclonal Gammopathy


subject: PUBCHEM.COMPOUND:46783403

object_name: IgM Monoclonal Gammopathy


subject: PUBCHEM.COMPOUND:46783403

object_name: IgG Monoclonal Gammopathy


subject: PUBCHEM.COMPOUND:46783403

object_name: IgG gammopathy


subject: PUBCHEM.COMPOUND:46783403


subject: PUBCHEM.COMPOUND:46783403

object_name: light chain deposition disease


subject: PUBCHEM.COMPOUND:46783403

object_name: Waldenstrom macroglobulinemia


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Oral Complication


subject: PR:000005931


subject: CHEBI:147398

subject_name: Tideglusib

object_name: autism spectrum disorder


subject: CHEBI:41948

subject_name: Eflornithine

object_name: Stomach cancer


subject: CHEBI:41948

object_name: gastric cancer


subject: CHEBI:41948

object_name: gastric intestinal metaplasia


subject: UMLS:C2827520

subject_name: Human Trefoil Factor 1-Secreting Lactococcus lactis AG013

object_name: Oral Mucositis


subject: UMLS:C2827520

object_name: stomatitis


subject: UMLS:C2827520

object_name: oral mucositis


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: malignant soft tissue neoplasm


subject: CHEBI:79699

object_name: sarcoma


subject: UMLS:C5555809

subject_name: Gallium Ga 68 FF58

object_name: glioblastoma


subject: UMLS:C5555809

object_name: Brain Stem Glioblastoma


subject: UMLS:C5555809

object_name: glioma susceptibility 1


subject: UMLS:C5555809

object_name: gastroesophageal adenocarcinoma


subject: UMLS:C5555809

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5555809

object_name: brain cancer


subject: UMLS:C5555809

object_name: brain neoplasm


subject: UNII:VC1D38AGN9

object_name: renal cell carcinoma


subject: UMLS:C3641005


subject: UMLS:C4482910

subject_name: meropenem / vaborbactam

object_name: ventilator-associated pneumonia


subject: UMLS:C4482910

object_name: Hospital acquired pneumonia


subject: PUBCHEM.COMPOUND:2759

subject_name: Cinepazide

object_name: Ischemic stroke


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: skin melanoma


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: UMLS:C5855614

subject_name: Copper Cu 64 GRIP B

object_name: non-Hodgkin lymphoma


subject: UMLS:C4083270

subject_name: BIBW 2992


subject: UMLS:C4083270

object_name: Childhood Glioblastoma


subject: UMLS:C4083270

object_name: adult glioblastoma


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: pediatric osteosarcoma


subject: UNII:52CMI0WC3Y

object_name: Osteosarcoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:0VCB95RHRV

subject_name: TAMNORZATINIB

object_name: Non-small cell lung cancer recurrent


subject: UNII:0VCB95RHRV

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:0VCB95RHRV

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UNII:0VCB95RHRV

object_name: Metastatic non-small cell lung cancer


subject: UNII:0VCB95RHRV

object_name: EGFR mutation-related tumors


subject: UMLS:C4527012

subject_name: Axl/Mer Inhibitor ONO-7475


subject: UMLS:C4527012


subject: UMLS:C4527012


subject: UMLS:C4527012


subject: UMLS:C4527012


subject: CHEBI:90948

subject_name: osimertinib mesylate


subject: CHEBI:90948


subject: CHEBI:90948


subject: CHEBI:90948


subject: CHEBI:90948


subject: CHEBI:2965

object_name: Vascular resistance (finding)


subject: UMLS:C0379142


subject: UNII:44OLL8XEJ4


subject: UMLS:C0253336


subject: CHEBI:6909

subject_name: Metronidazole

object_name: periodontitis, aggressive 1


subject: CHEBI:6909

object_name: acute pericementitis


subject: UMLS:C5206408

subject_name: Furosemide/Digoxin Topical Gel CLS003

object_name: Cutaneous warts


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: Advanced cancer


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Skin toxicity


subject: CHEBI:60648

object_name: metastatic colorectal cancer


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54681072

subject_name: Omadacycline

object_name: Community-Acquired Pneumonia


subject: UNII:090IP5RV8F


subject: CHEBI:6801

subject_name: Metformin

object_name: metabolic disturbance


subject: CHEBI:6801

object_name: familial hyperprolactinemia


subject: CHEBI:6801

object_name: acquired hyperprolactinemia


subject: CHEBI:6801

object_name: hyperprolactinemia


subject: UMLS:C0021641

subject_name: Insulin

object_name: liver cirrhosis


subject: UMLS:C5556436

subject_name: ALVAC gp100 Vaccine

object_name: metastatic melanoma


subject: UMLS:C5556436

object_name: skin neoplasm


subject: UMLS:C5556436

object_name: skin cancer


subject: PR:000015975

subject_name: sperm motility kinase Tcr mutant form


subject: PR:000015975


subject: UMLS:C0034790

subject_name: T-Cell Receptor


subject: UMLS:C0034790


subject: UMLS:C4733631


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Adult Mixed Glioma


subject: CHEBI:45716

object_name: Adult Anaplastic Oligodendroglioma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: estrogen receptor-negative breast cancer


subject: UNII:2S9ZZM9Q9V

object_name: progesterone receptor-negative breast cancer


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Her2-receptor negative breast cancer


subject: CHEBI:114785

object_name: triple-negative breast carcinoma


subject: CHEBI:114785

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:114785


subject: CHEBI:114785


subject: PUBCHEM.COMPOUND:72562361

subject_name: Ceftaroline fosamil

object_name: kidney disorder


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: Compulsion


subject: PUBCHEM.COMPOUND:1971

subject_name: ent-Abacavir

object_name: High grade glioma


subject: PUBCHEM.COMPOUND:1971

object_name: malignant glioma


subject: CHEBI:421707

subject_name: Abacavir


subject: CHEBI:421707


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:63577


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:45409


subject: UMLS:C0665297

subject_name: natalizumab


subject: UMLS:C0051427

subject_name: Demser

object_name: prostate carcinoma


subject: UMLS:C0051427

object_name: prostate cancer


subject: CHEMBL.COMPOUND:CHEMBL5095287

subject_name: ROSNILIMAB

object_name: alopecia areata


subject: CHEMBL.COMPOUND:CHEMBL5095287

object_name: alopecia


subject: UMLS:C5670503

subject_name: Rosnilimab


subject: UMLS:C5670503


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:71301229

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:71301229

object_name: Solid Neoplasm


subject: CHEBI:73611

subject_name: Met-Gly

object_name: male infertility


subject: CHEBI:25107

subject_name: magnesium atom


subject: PR:000004501

subject_name: attractin


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C4733690

subject_name: BTK Inhibitor ICP-022

object_name: diffuse large B-cell lymphoma


subject: UMLS:C4287681

object_name: Advanced Hepatocellular Carcinoma


subject: CHEBI:6062

subject_name: Isosorbide mononitrate

object_name: IUD insertion complication


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Locally Advanced Esophageal Squamous Cell Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Plasma cell myeloma recurrent


subject: CHEBI:2038

subject_name: Azacitidine


subject: UMLS:C1134558

subject_name: Chinese Herbs


subject: UMLS:C4705188

object_name: cystic fibrosis


subject: UMLS:C0879373

subject_name: Iodinated Contrast Agent

object_name: cervical cancer


subject: UMLS:C0879373

object_name: cervical carcinoma


subject: CHEBI:125427

object_name: pancreatic neoplasm


subject: CHEBI:125427

object_name: exocrine pancreatic carcinoma


subject: CHEBI:125427

object_name: malignant pancreatic neoplasm


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:231425

subject_name: tolvaptan

object_name: Calcium phosphate nephrolithiasis


subject: CHEBI:231425

object_name: nephrolithiasis, calcium oxalate


subject: CHEBI:231425

object_name: nephrolithiasis susceptibility caused by SLC26A1


subject: CHEBI:231425

object_name: nephrolithiasis


subject: UMLS:C1725180

subject_name: ranibizumab ophthalmic

object_name: Bilateral retinopathy of prematurity


subject: UMLS:C1725180

object_name: Premature birth


subject: UMLS:C1725180

object_name: premature birth (history)


subject: UMLS:C1725180

object_name: retinal disease


subject: UMLS:C1725180

object_name: eye disorder


subject: UNII:96265TNH2R

subject_name: Gedatolisib

object_name: HER2 positive breast carcinoma


subject: UMLS:C5237257

subject_name: Anti-HIV-1 Lentiviral Vector-expressing sh5/C46 Cal-1

object_name: HIV-1 infection


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: binge eating


subject: CHEBI:16796

subject_name: Melatonin


subject: PUBCHEM.COMPOUND:165411833

subject_name: PAFOLACIANINE

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:165411833

object_name: prostate cancer


subject: UNII:F7BD3Z4X8L

subject_name: Pafolacianine


subject: UNII:F7BD3Z4X8L


subject: CHEBI:73589

subject_name: Leu-Thr

object_name: poliomyelitis


subject: CHEBI:188719

subject_name: Ertugliflozin

object_name: Insulin resistance


subject: CHEBI:188719

object_name: cardiovascular disorder


subject: CHEBI:188719

object_name: arteriosclerosis disorder


subject: CHEBI:188719

object_name: atherosclerosis


subject: UNII:V77J4WJF9Z

subject_name: imgatuzumab

object_name: skin squamous cell carcinoma


subject: UNII:V77J4WJF9Z

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C3253111


subject: UMLS:C3253111


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: grade 3B follicular lymphoma


subject: UMLS:C5206892

subject_name: epcoritamab


subject: CHEBI:148438

object_name: Regenerative inflammation


subject: PUBCHEM.COMPOUND:115276

subject_name: hexametaphosphate


subject: CHEBI:74790

subject_name: Pro-Ile


subject: CHEBI:53806

subject_name: phenyl isocyanate


subject: CHEBI:35780

subject_name: phosphate ion


subject: CHEBI:28874

subject_name: phosphatidylinositol


subject: CHEBI:61484

subject_name: polyimide polymer


subject: PR:000014678


subject: PUBCHEM.COMPOUND:86217377

subject_name: Oxybutynin AL

object_name: Hot Flashes, CTCAE


subject: PUBCHEM.COMPOUND:86217377

object_name: Hot flashes


subject: PUBCHEM.COMPOUND:86217377

object_name: Menopause present (finding)


subject: PUBCHEM.COMPOUND:86217377

object_name: Menopause


subject: CHEBI:144551

subject_name: Oxybutynin


subject: CHEBI:144551


subject: CHEBI:144551


subject: CHEBI:144551


subject: CHEBI:230430

subject_name: Ulinastatin

object_name: congenital heart disease


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: UMLS:C0077906


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b


subject: UNII:G8RGG88B68

object_name: squamous cell carcinoma


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: esophageal adenocarcinoma


subject: UNII:9G6U5L461Q

object_name: cervical adenocarcinoma


subject: UNII:9G6U5L461Q

object_name: adenocarcinoma


subject: UNII:9G6U5L461Q

object_name: bile duct adenocarcinoma


subject: UNII:9G6U5L461Q

object_name: gastric adenocarcinoma


subject: CHEBI:3380

subject_name: Captopril

object_name: type 1 diabetes mellitus 1


subject: CHEBI:3380

object_name: type 1 diabetes mellitus


subject: UMLS:C0006938

subject_name: captopril


subject: UMLS:C0006938


subject: CHEBI:16347

subject_name: Levocarnitine


subject: CHEBI:91951

object_name: low grade serous adenocarcinoma of ovary


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: UMLS:C2347328

subject_name: sirolimus protein-bound particles


subject: CHEBI:2704

subject_name: Anastrozole

object_name: precocious puberty


subject: CHEBI:144094

subject_name: bicalutamide


subject: UNII:F333OQQ9UV

object_name: adult glioblastoma


subject: UMLS:C2983762


subject: CHEBI:90936

subject_name: Alectinib


subject: PUBCHEM.COMPOUND:76022323

subject_name: Idasanutlin


subject: CHEBI:91899

object_name: Bronchospasm, Exercise-Induced


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:52603

object_name: Endotoxemia


subject: GTOPDB:5019

subject_name: LPS


subject: CHEBI:16412

subject_name: Lysophosphotidylserine


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: PR:000001155

subject_name: Toll-like receptor 4


subject: UMLS:C3883914

subject_name: ECa 233 extract

object_name: temporomandibular joint disorder


subject: UMLS:C4722737

subject_name: AXS 05

object_name: Agitation, CTCAE 3.0


subject: UMLS:C4722737

object_name: Agitation, CTCAE 5.0


subject: UMLS:C0699706

subject_name: Gestapuran

object_name: Menopause present (finding)


subject: UMLS:C0699706

object_name: Menopause


subject: UMLS:C4287766

object_name: biliary tract cancer


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL

object_name: Overweight and obesity


subject: UNII:7K3W1BIU6K

subject_name: Triethylhexanoin


subject: UNII:7K3W1BIU6K

object_name: type 2 diabetes mellitus


subject: CHEBI:76978

subject_name: Tricaprylin


subject: CHEBI:76978


subject: UMLS:C3897088

subject_name: Oral Azacitidine

object_name: grade 3B follicular lymphoma


subject: UMLS:C3897088

object_name: high grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement


subject: UMLS:C3897088

object_name: Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UMLS:C3897088

object_name: high-grade B-cell lymphoma double-hit/triple-hit


subject: UMLS:C3897088

object_name: Triple hit lymphoma


subject: UMLS:C3897088

object_name: diffuse large B-cell lymphoma activated B-cell type


subject: UMLS:C3897088

object_name: diffuse large B-cell lymphoma germinal center B-cell type


subject: UMLS:C3897088

object_name: intravascular large B-cell lymphoma


subject: UMLS:C3897088

object_name: Stage III Diffuse Large B-Cell Lymphoma


subject: UMLS:C3897088

object_name: Stage IV Diffuse Large B-Cell Lymphoma


subject: UMLS:C3897088

object_name: Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UMLS:C3897088

object_name: primary cutaneous diffuse large B-cell lymphoma, Leg type


subject: UMLS:C3897088

object_name: Ann Arbor Stage IIX (Bulky) Diffuse Large B-Cell Lymphoma


subject: UMLS:C3897088

object_name: diffuse large B-cell lymphoma with chronic inflammation


subject: UMLS:C3897088

object_name: T-cell/histiocyte rich large B cell lymphoma


subject: UMLS:C3897088

object_name: HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C3897088

object_name: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly


subject: UMLS:C3897088

object_name: High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C3897088

object_name: nodular lymphocyte predominant Hodgkin lymphoma


subject: UMLS:C3897088

object_name: lymphoplasmacytic lymphoma


subject: UMLS:C3897088

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: Post-ERCP acute pancreatitis


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0358845

subject_name: Analgesics and non-steroidal anti-inflammatory drugs


subject: UNII:O9BP19HZ3Q

object_name: Chronic low back pain


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Unresectable Melanoma


subject: CHEBI:61057

object_name: metastatic melanoma


subject: CHEBI:61057

object_name: Unresectable Basal Cell Carcinoma


subject: CHEBI:61057

object_name: Unresectable Merkel Cell Carcinoma


subject: CHEBI:61057

object_name: Metastatic basal cell carcinoma


subject: CHEBI:61057

object_name: Metastatic Merkel cell carcinoma


subject: CHEBI:61057

object_name: Skin squamous cell carcinoma metastatic


subject: CHEBI:61057

object_name: Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8


subject: CHEBI:61057

object_name: Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:61057

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:61057

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:61057

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:61057

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:61057

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:61057

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:61057

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:5372

object_name: Unresectable Melanoma


subject: PUBCHEM.COMPOUND:5372

object_name: metastatic melanoma


subject: PUBCHEM.COMPOUND:5372

object_name: Unresectable Basal Cell Carcinoma


subject: PUBCHEM.COMPOUND:5372

object_name: Unresectable Merkel Cell Carcinoma


subject: PUBCHEM.COMPOUND:5372

object_name: Metastatic basal cell carcinoma


subject: PUBCHEM.COMPOUND:5372

object_name: Metastatic Merkel cell carcinoma


subject: PUBCHEM.COMPOUND:5372

object_name: Skin squamous cell carcinoma metastatic


subject: PUBCHEM.COMPOUND:5372

object_name: Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:5372

object_name: Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:5372

object_name: Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:5372

object_name: Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:5372

object_name: Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:5372

object_name: Pathologic Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:5372

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:5372

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:5372

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:5372

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:5372

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:5372

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:5372

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:5372

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: Unresectable Melanoma


subject: CHEBI:61049

object_name: metastatic melanoma


subject: CHEBI:61049

object_name: Unresectable Basal Cell Carcinoma


subject: CHEBI:61049

object_name: Unresectable Merkel Cell Carcinoma


subject: CHEBI:61049

object_name: Metastatic basal cell carcinoma


subject: CHEBI:61049

object_name: Metastatic Merkel cell carcinoma


subject: CHEBI:61049

object_name: Skin squamous cell carcinoma metastatic


subject: CHEBI:61049

object_name: Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8


subject: CHEBI:61049

object_name: Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8


subject: CHEBI:61049

object_name: Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8


subject: CHEBI:61049

object_name: Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8


subject: CHEBI:61049

object_name: Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8


subject: CHEBI:61049

object_name: Pathologic Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8


subject: CHEBI:61049

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:61049

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:61049

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:61049

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:61049

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:61049

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:61049

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:61049

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: UMLS:C5447427

subject_name: Anti-CFH Monoclonal Antibody GT103

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C5447427

object_name: Non-small cell lung cancer recurrent


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: adult acute myeloid leukemia


subject: GTOPDB:4942

object_name: childhood acute myeloid leukemia


subject: GTOPDB:4942

object_name: Leukemia - chronic myeloid leukemia (CML)


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: PR:000016426

subject_name: voltage-dependent calcium channel gamma-like subunit

object_name: Myelodysplasia


subject: PR:000016426


subject: PR:000016426


subject: PR:000016426

object_name: acute myeloid leukemia


subject: PR:000016426

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PR:000016426


subject: PR:000017230

subject_name: vomeronasal type-1 receptor A1


subject: PR:000017230


subject: PR:000017230


subject: PR:000017230


subject: PR:000017230


subject: PR:000017230


subject: UMLS:C0879440

subject_name: PR1 leukemia peptide vaccine


subject: UMLS:C0879440


subject: UMLS:C0879440


subject: UMLS:C0879440


subject: UMLS:C0879440


subject: UMLS:C0879440


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: AIDS-Related Hodgkin Lymphoma


subject: UMLS:C1832035


subject: CHEBI:4305

subject_name: dacarbazine


subject: CHEBI:4305

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:4305

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:4305

object_name: Ann Arbor Stage IIIB Hodgkin Lymphoma


subject: CHEBI:4305

object_name: Ann Arbor Stage IIIA Hodgkin Lymphoma


subject: CHEBI:4305

object_name: Ann Arbor Stage IVA Hodgkin Lymphoma


subject: CHEBI:4305

object_name: Ann Arbor Stage IVB Hodgkin Lymphoma


subject: CHEBI:4305

object_name: HIV infection


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Advanced Melanoma


subject: CHEBI:72317

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:72317

object_name: Advanced Head and Neck Carcinoma


subject: CHEBI:72317

object_name: Advanced Kaposi Sarcoma


subject: CHEBI:72317

object_name: Advanced Lung Small Cell Carcinoma


subject: CHEBI:72317

object_name: Advanced Urothelial Carcinoma


subject: CHEBI:72317

object_name: Advanced Prostate Carcinoma


subject: CHEBI:72317

object_name: Advanced Ovarian Carcinoma


subject: CHEBI:72317

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: CHEBI:72317

object_name: Advanced Triple-Negative Breast Carcinoma


subject: CHEBI:72317

object_name: Advanced Thyroid Gland Medullary Carcinoma


subject: CHEBI:72317

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:72317

object_name: Advanced Differentiated Thyroid Gland Carcinoma


subject: CHEBI:72317

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:72317

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:72317

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:72317

object_name: Small cell lung cancer recurrent


subject: CHEBI:72317

object_name: Stage III Differentiated Thyroid Gland Carcinoma AJCC v8


subject: CHEBI:72317

object_name: Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8


subject: CHEBI:72317

object_name: Recurrent Differentiated Thyroid Gland Carcinoma


subject: CHEBI:72317

object_name: Metastatic Lung Small Cell Carcinoma


subject: CHEBI:72317

object_name: Metastatic Differentiated Thyroid Gland Carcinoma


subject: CHEBI:72317

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:72317

object_name: Stage III Thyroid Gland Medullary Carcinoma AJCC v8


subject: CHEBI:72317

object_name: Stage IV Thyroid Gland Medullary Carcinoma AJCC v8


subject: CHEBI:72317

object_name: Metastatic Thyroid Gland Medullary Carcinoma


subject: CHEBI:72317

object_name: Recurrent Triple-Negative Breast Carcinoma


subject: CHEBI:72317

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: CHEBI:72317

object_name: Stage III Hepatocellular Carcinoma AJCC v8


subject: CHEBI:72317

object_name: Stage IV Hepatocellular Carcinoma AJCC v8


subject: CHEBI:72317

object_name: Urothelial carcinoma recurrent


subject: CHEBI:72317

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:72317

object_name: Recurrent Kaposi Sarcoma


subject: CHEBI:72317

object_name: Kaposi's sarcoma, metastatic


subject: CHEBI:231614

object_name: Advanced Head and Neck Carcinoma


subject: CHEBI:231614

object_name: Advanced Kaposi Sarcoma


subject: CHEBI:231614

object_name: Advanced Lung Small Cell Carcinoma


subject: CHEBI:231614

object_name: Advanced Urothelial Carcinoma


subject: CHEBI:231614

object_name: Advanced Prostate Carcinoma


subject: CHEBI:231614

object_name: Advanced Ovarian Carcinoma


subject: CHEBI:231614

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:231614

object_name: Advanced Triple-Negative Breast Carcinoma


subject: CHEBI:231614

object_name: Advanced Thyroid Gland Medullary Carcinoma


subject: CHEBI:231614

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:231614

object_name: Advanced Differentiated Thyroid Gland Carcinoma


subject: CHEBI:231614

object_name: Renal cell carcinoma recurrent


subject: CHEBI:231614

object_name: Stage III Differentiated Thyroid Gland Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Head and neck cancer metastatic


subject: CHEBI:231614

object_name: Recurrent Differentiated Thyroid Gland Carcinoma


subject: CHEBI:231614

object_name: Metastatic Lung Small Cell Carcinoma


subject: CHEBI:231614

object_name: Metastatic Differentiated Thyroid Gland Carcinoma


subject: CHEBI:231614

object_name: Stage III Thyroid Gland Medullary Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Stage IV Thyroid Gland Medullary Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Recurrent Thyroid Gland Medullary Carcinoma


subject: CHEBI:231614

object_name: Metastatic Thyroid Gland Medullary Carcinoma


subject: CHEBI:231614

object_name: Recurrent Triple-Negative Breast Carcinoma


subject: CHEBI:231614

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: CHEBI:231614

object_name: Recurrent Kaposi Sarcoma


subject: CHEBI:231614

object_name: Kaposi's sarcoma, metastatic


subject: UMLS:C2346820

object_name: Advanced Head and Neck Carcinoma


subject: UMLS:C2346820

object_name: Advanced Kaposi Sarcoma


subject: UMLS:C2346820

object_name: Advanced Lung Small Cell Carcinoma


subject: UMLS:C2346820

object_name: Advanced Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Advanced Prostate Carcinoma


subject: UMLS:C2346820

object_name: Advanced Ovarian Carcinoma


subject: UMLS:C2346820

object_name: Stage III Prostate Cancer AJCC v8


subject: UMLS:C2346820

object_name: Advanced Triple-Negative Breast Carcinoma


subject: UMLS:C2346820

object_name: Advanced Thyroid Gland Medullary Carcinoma


subject: UMLS:C2346820

object_name: Stage III Ovarian Cancer AJCC v8


subject: UMLS:C2346820

object_name: Advanced Differentiated Thyroid Gland Carcinoma


subject: UMLS:C2346820

object_name: Renal cell carcinoma recurrent


subject: UMLS:C2346820

object_name: Stage III Differentiated Thyroid Gland Carcinoma AJCC v8


subject: UMLS:C2346820

object_name: Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8


subject: UMLS:C2346820

object_name: Head and neck cancer metastatic


subject: UMLS:C2346820

object_name: Recurrent Differentiated Thyroid Gland Carcinoma


subject: UMLS:C2346820

object_name: Metastatic Lung Small Cell Carcinoma


subject: UMLS:C2346820

object_name: Metastatic Differentiated Thyroid Gland Carcinoma


subject: UMLS:C2346820

object_name: Stage III Thyroid Gland Medullary Carcinoma AJCC v8


subject: UMLS:C2346820

object_name: Stage IV Thyroid Gland Medullary Carcinoma AJCC v8


subject: UMLS:C2346820

object_name: Recurrent Thyroid Gland Medullary Carcinoma


subject: UMLS:C2346820

object_name: Metastatic Thyroid Gland Medullary Carcinoma


subject: UMLS:C2346820

object_name: Recurrent Triple-Negative Breast Carcinoma


subject: UMLS:C2346820

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: UMLS:C2346820

object_name: Recurrent Kaposi Sarcoma


subject: UMLS:C2346820

object_name: Kaposi's sarcoma, metastatic


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: melanoma


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: PUBCHEM.COMPOUND:127236

object_name: solitary osseous plasmacytoma


subject: PUBCHEM.COMPOUND:127236

object_name: plasma cell neoplasm


subject: PR:000001406

subject_name: tumor necrosis factor receptor superfamily member 17


subject: PR:000001406


subject: UMLS:C4053685

object_name: non-small cell lung carcinoma


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Malignant neoplasm of stomach stage III


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Effects of chemotherapy


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Pancreatic carcinoma stage II


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:141969


subject: CHEBI:141969

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:141969

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:141969

object_name: Pancreatic carcinoma stage III


subject: CHEBI:141969

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:141969

object_name: pancreatic adenocarcinoma


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: CHEBI:174615

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:174615

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:49956

subject_name: Xenon

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:49956

object_name: COPD, severe early onset


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: drug-induced liver injury


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Drug Interactions


subject: CHEBI:36791

object_name: Adverse drug interaction


subject: CHEBI:36791


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: RXCUI:57773

subject_name: Unasyn

object_name: cleft palate


subject: CHEBI:44915

subject_name: Propofol

object_name: Status epilepticus


subject: CHEBI:9561

subject_name: Thiopental


subject: CHEBI:102166


subject: CHEBI:7983

subject_name: Pentobarbital